Prevalence and risk evaluation of cardiovascular disease in the newly diagnosed prostate cancer population in China. (IMAGE)

Beijing Zhongke Journal Publising Co. Ltd.

Prevalence and risk evaluation of cardiovascular disease in the newly diagnosed prostate cancer population in China.

Caption

This study, originating from 34 medical centers across China, collected clinical data from nearly 5,000 prostate cancer patients. After data cleansing, a total of 4,253 cases were included for analysis. The findings revealed that 26.97% of patients were diagnosed with cardiovascular disease (CVD) at the time of their prostate cancer diagnosis. Nearly half of the patients had concomitant hypertension, with half of these cases being poorly controlled. Over 95% of patients faced moderate to high risk of CVD. Patients receiving Androgen Deprivation Therapy (ADT) exhibited a higher risk of CVD. The main results of this study were shared at the 2023 ESMO conference.

Credit

Beijing Zhongke Journal Publising Co. Ltd.

Usage Restrictions

Credit must be given to the creator.

License

CC BY

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.